Home
/
CAPRICOR THERAPEUTICS, INC.
/
Financials
/
Quarterly
CAPRICOR THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CAPRICOR THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2024
$2.26M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$3.97M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$4.91M
May 14, 2025
Q3
2024
Sep 30, 2023
$6.19M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$3.92M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$2.99M
May 14, 2024
Q3
2023
Sep 30, 2022
$1.59M
Nov 14, 2023
Q3
2022
Sep 30, 2021
$244.9K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$204.1K
Aug 12, 2022
Q1
2022
Mar 31, 2021
$40.8K
May 11, 2022
Q3
2021
Sep 30, 2020
$16.9K
Nov 12, 2021
Q2
2021
Jun 30, 2020
$49.9K
Aug 13, 2021
Q1
2021
Mar 31, 2020
$185.7K
May 14, 2021
Q3
2020
Sep 30, 2019
$142.1K
Nov 13, 2020
Q2
2020
Jun 30, 2019
$410.4K
Aug 10, 2020
Q1
2020
Mar 31, 2019
$230.5K
May 15, 2020
Q3
2018
Sep 30, 2018
$219.2K
Nov 14, 2018
Q2
2018
Jun 30, 2018
$404.0K
Aug 13, 2018
Q1
2018
Mar 31, 2018
$400.1K
May 14, 2018
Q3
2018
Sep 30, 2017
$313.3K
Nov 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($24.57M)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($25.91M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($25.91M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($24.39M)
May 14, 2025
Q2
2025
Mar 31, 2025
($24.39M)
Aug 11, 2025
Q3
2025
Mar 31, 2025
($24.39M)
Nov 10, 2025
Q3
2025
Sep 30, 2024
($12.56M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($11.00M)
Aug 11, 2025
Q3
2025
Jun 30, 2024
($11.00M)
Nov 10, 2025
Q3
2025
Mar 31, 2024
($9.79M)
Nov 10, 2025
Q1
2025
Mar 31, 2024
($9.79M)
May 14, 2025
Q2
2025
Mar 31, 2024
($9.79M)
Aug 11, 2025
Q3
2024
Sep 30, 2023
($6.39M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($7.37M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($7.37M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($7.77M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($7.77M)
May 14, 2024
Q3
2024
Mar 31, 2023
($7.77M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($6.37M)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($7.11M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($26.28M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($27.72M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($24.98M)
May 14, 2025
Q3
2025
Sep 30, 2024
($13.01M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($11.59M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($10.27M)
May 14, 2025
Q3
2024
Sep 30, 2023
($6.86M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($7.75M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($8.18M)
May 14, 2024
Q3
2023
Sep 30, 2022
($6.48M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($7.32M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($7.83M)
May 12, 2023
Q3
2022
Sep 30, 2021
($4.31M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($5.08M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($5.16M)
May 11, 2022
Q3
2021
Sep 30, 2020
($3.91M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($3.49M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($2.11M)
May 14, 2021
Q3
2020
Sep 30, 2019
($1.63M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($2.07M)
Aug 10, 2020